Gut microbiota and colorectal cancer
暂无分享,去创建一个
[1] S. Larsson,et al. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. , 2005, Journal of the National Cancer Institute.
[2] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[3] H. Sokol,et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease , 2015, Gut.
[4] Tomas Hrncir,et al. Nod2 is required for the regulation of commensal microbiota in the intestine , 2009, Proceedings of the National Academy of Sciences.
[5] Shizuo Akira,et al. Toll-like receptor signalling , 2004, Nature Reviews Immunology.
[6] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[7] P. Laird,et al. Association between molecular subtypes of colorectal cancer and patient survival. , 2015, Gastroenterology.
[8] D. Philpott,et al. Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis , 2013, Gut microbes.
[9] M. Meyerson,et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. , 2013, Cell host & microbe.
[10] Bas E Dutilh,et al. A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects , 2012, Nature Reviews Microbiology.
[11] K. Strissel,et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice , 2014, The ISME Journal.
[12] A. Jemal,et al. Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.
[13] B. Weimer,et al. Cross-talk between E. coli strains and a human colorectal adenocarcinoma-derived cell line , 2013, Scientific Reports.
[14] P. Gibson,et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment , 2014, Gut.
[15] M. R. Rubinstein,et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. , 2013, Cell host & microbe.
[16] É. Oswald,et al. Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria , 2015, Gut.
[17] H. Qin,et al. Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer. , 2015, Molecular medicine reports.
[18] A. Weintraub,et al. Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] Hiromu Suzuki,et al. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway , 2015, International journal of cancer.
[20] F. Bushman,et al. Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.
[21] Jarkko Salojärvi,et al. Effects of bowel cleansing on the intestinal microbiota , 2014, Gut.
[22] P. Schloss,et al. The Human Gut Microbiome as a Screening Tool for Colorectal Cancer , 2014, Cancer Prevention Research.
[23] Cynthia L Sears,et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses , 2009, Nature Medicine.
[24] D. Philpott,et al. Commensal and Probiotic Bacteria Influence Intestinal Barrier Function and Susceptibility to Colitis in Nod1−/−;Nod2−/− Mice , 2012, Inflammatory bowel diseases.
[25] Jun Yu,et al. Gut mucosal microbiome across stages of colorectal carcinogenesis , 2015, Nature Communications.
[26] W. D. de Vos,et al. Impact of diet on human intestinal microbiota and health. , 2014, Annual review of food science and technology.
[27] Lennart Sjöberg,et al. Ahlstrand E , Persson L , Tidefelt U , Söderquist B. Alteration of the colonization pattern of coagulase-negative staphylococci in patients undergoing treatment for hematological malignancy. Eur J Clin Microbiol Infect Dis , 2011 .
[28] S. Spanò,et al. A Bacterial Pathogen Targets a Host Rab-Family GTPase Defense Pathway with a GAP. , 2016, Cell host & microbe.
[29] M. Rothe,et al. Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.
[30] E. Elinav,et al. NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells , 2012, Nature.
[31] D. Golenbock,et al. Induction of Persistent Colitis by a Human Commensal, Enterotoxigenic Bacteroides fragilis, in Wild-Type C57BL/6 Mice , 2009, Infection and Immunity.
[32] C. Alpuche-Aranda,et al. This information is current as Activation and Cell Death Cells by Preventing Inflammasome Expression To Promote Its Survival in B Family CARD Domain Containing Protein 4 Downregulates Nod-like Receptor Salmonella , 2013 .
[33] M. Toyota,et al. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. , 2014, Cancer research.
[34] D. Philpott,et al. Nod-like proteins in immunity, inflammation and disease , 2006, Nature Immunology.
[35] D. Pezet,et al. Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. , 2014, World journal of gastroenterology.
[36] Nathalie M. Delzenne,et al. Towards a more comprehensive concept for prebiotics , 2015, Nature Reviews Gastroenterology &Hepatology.
[37] P. Goldberg,et al. Quantitative Profiling of Colorectal Cancer-Associated Bacteria Reveals Associations between Fusobacterium spp., Enterotoxigenic Bacteroides fragilis (ETBF) and Clinicopathological Features of Colorectal Cancer , 2015, PloS one.
[38] Jesse D. Martinez,et al. Differential Regulation of EGFR–MAPK Signaling by Deoxycholic Acid (DCA) and Ursodeoxycholic Acid (UDCA) in Colon Cancer , 2014, Digestive Diseases and Sciences.
[39] M. Delledonne,et al. Deciphering bifidobacterial-mediated metabolic interactions and their impact on gut microbiota by a multi-omics approach , 2016, The ISME Journal.
[40] Justine W. Debelius,et al. Specialized metabolites from the microbiome in health and disease. , 2014, Cell metabolism.
[41] C. Sears,et al. Enterotoxigenic Bacteroides fragilis (ETBF)-mediated colitis in Min (Apc+/-) mice: a human commensal-based murine model of colon carcinogenesis , 2010, Cell cycle.
[42] H. Harmsen,et al. Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses , 2016, Scientific Reports.
[43] E. Murphy,et al. Exercise and associated dietary extremes impact on gut microbial diversity , 2014, Gut.
[44] S. Sørensen,et al. Synbiotic Lactobacillus acidophilus NCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: a randomized, double-blinded cross-over trial. , 2014, FEMS microbiology ecology.
[45] W. Marlicz,et al. The effect of exercise and diet on gut microbial diversity , 2014, Gut.
[46] S. Jonjić,et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. , 2015, Immunity.
[47] Gabriel Núñez,et al. Intracellular NOD-like receptors in host defense and disease. , 2007, Immunity.
[48] S. Park,et al. Enteropathogenic Escherichia coli-induced macrophage inhibitory cytokine 1 mediates cancer cell survival: an in vitro implication of infection-linked tumor dissemination , 2013, Oncogene.
[49] Qiang Feng,et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer , 2015, Gut.
[50] M. Hornef,et al. Real friends: Faecalibacterium prausnitzii supports mucosal immune homeostasis , 2015, Gut.
[51] C. Sears,et al. The toxins of Bacteroides fragilis. , 2001, Toxicon : official journal of the International Society on Toxinology.
[52] T. Weir,et al. Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. , 2015, Cell host & microbe.
[53] E. Allen-Vercoe,et al. Fusobacterium nucleatum Infection of Colonic Cells Stimulates MUC2 Mucin and Tumor Necrosis Factor Alpha , 2011, Infection and Immunity.
[54] F. Ginhoux,et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota , 2015, Science.
[55] Cynthia L Sears,et al. Microbes, microbiota, and colon cancer. , 2014, Cell host & microbe.
[56] Paolo Vineis,et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. , 2005, Journal of the National Cancer Institute.
[57] M. Donnenberg,et al. An Escherichia coli Effector Protein Promotes Host Mutation via Depletion of DNA Mismatch Repair Proteins , 2013, mBio.
[58] P. Godowski,et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. , 1999, Science.
[59] Lawrence A. David,et al. Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.
[60] C. Xiang,et al. Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer , 2012, PloS one.
[61] Taro Kawai,et al. Toll-Like Receptor Signaling Pathways , 2014, Front. Immunol..
[62] S. Akira,et al. Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.
[63] B. Peleteiro,et al. Dietary patterns and colorectal cancer: systematic review and meta-analysis , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[64] Belgin Dogan,et al. Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota , 2012, Science.
[65] Mathieu Almeida,et al. Dietary intervention impact on gut microbial gene richness , 2013, Nature.
[66] Haitao Wen,et al. Mechanisms of NOD-like receptor-associated inflammasome activation. , 2013, Immunity.
[67] David A. Relman,et al. Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota , 2012, Cell.
[68] Jason B. Williams,et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy , 2015, Science.
[69] Ruth Ley,et al. Unravelling the effects of the environment and host genotype on the gut microbiome , 2011, Nature Reviews Microbiology.
[70] Patrick D Schloss,et al. Structure of the gut microbiome following colonization with human feces determines colonic tumor burden , 2014, Microbiome.
[71] J. Raisch,et al. Intracellular colon cancer-associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression , 2015, Laboratory Investigation.
[72] Emmanuel Buc,et al. Colonization of the Human Gut by E. coli and Colorectal Cancer Risk , 2013, Clinical Cancer Research.
[73] C. Hart,et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. , 2004, Gastroenterology.
[74] Jan Verhaegen,et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis , 2013, Gut.
[75] F. Gusovsky,et al. Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction* , 1999, The Journal of Biological Chemistry.
[76] J. Crawford,et al. The colibactin warhead crosslinks DNA , 2015, Nature chemistry.
[77] C. Hart,et al. A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenicity islands with urinary pathogenic E. coli. , 2008, Microbiology.
[78] Alicja Wolk,et al. Meat consumption and risk of colorectal cancer: A meta‐analysis of prospective studies , 2006, International journal of cancer.
[79] J. Goedert,et al. Human gut microbiome and risk for colorectal cancer. , 2013, Journal of the National Cancer Institute.
[80] Elhanan Borenstein,et al. Extensive Strain-Level Copy-Number Variation across Human Gut Microbiome Species , 2015, Cell.
[81] M. Ebert,et al. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome , 2014, European Journal of Clinical Microbiology & Infectious Diseases.
[82] T. Giese,et al. Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.
[83] Stephanie A. Bien,et al. Genetic architecture of colorectal cancer , 2015, Gut.
[84] D. Douek,et al. Microbial translocation across the GI tract. , 2012, Annual review of immunology.
[85] Akiko Iwasaki,et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[86] Herbert Tilg,et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence , 2015 .
[87] G. Hajishengallis,et al. The keystone-pathogen hypothesis , 2012, Nature Reviews Microbiology.
[88] S. Pettersson,et al. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. , 2012, Carcinogenesis.
[89] C. Huttenhower,et al. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. , 2015, JAMA oncology.
[90] J. Parkhill,et al. Modulation of the human gut microbiota by dietary fibres occurs at the species level , 2016, BMC Biology.
[91] D. Pezet,et al. High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer , 2013, PloS one.
[92] A. Israël,et al. Invasive Shigella flexneri Activates NF-κB Through a Lipopolysaccharide-Dependent Innate Intracellular Response and Leads to IL-8 Expression in Epithelial Cells1 , 2000, The Journal of Immunology.
[93] Y. Iwakura,et al. Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis. , 2014, Immunity.
[94] W. Thabet,et al. Enteropathogenic Escherichia coli (EPEC): Does it have a role in colorectal tumourigenesis? A Prospective Cohort Study. , 2015, International journal of surgery.
[95] Patrice D. Cani,et al. Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling , 2015, Cell metabolism.
[96] D. Brenner,et al. Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation. , 2016, Cell host & microbe.
[97] D. Šmajs,et al. Escherichia colistrains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia , 2014, BMC Infectious Diseases.
[98] F. Ryan,et al. Tumour-associated and non-tumour-associated microbiota in colorectal cancer , 2016, Gut.
[99] Liping Zhao,et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers , 2011, The ISME Journal.
[100] J. Petrosino,et al. The Gut Microbiome Modulates Colon Tumorigenesis , 2013, mBio.
[101] C. Sears,et al. Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. , 2014, The Journal of clinical investigation.
[102] Mingyang Song,et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis , 2015, Gut.
[103] H. Qin,et al. Microbiota disbiosis is associated with colorectal cancer , 2015, Front. Microbiol..
[104] T. Pischon,et al. Obesity and colorectal cancer. , 2013, Frontiers in bioscience.
[105] G. Núñez,et al. Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens. , 2016, Immunity.
[106] A. Gupta,et al. Streptococcus bovis endocarditis, a silent sign for colonic tumour , 2010, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[107] Jens Roat Kultima,et al. Potential of fecal microbiota for early‐stage detection of colorectal cancer , 2014 .
[108] Martyn F. Symmons,et al. Assembly and localization of Toll-like receptor signalling complexes , 2014, Nature Reviews Immunology.
[109] Jun Yu,et al. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment , 2015, Oncotarget.
[110] Yongzhi Yang,et al. Analysis of the Intestinal Lumen Microbiota in an Animal Model of Colorectal Cancer , 2014, PloS one.
[111] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[112] A. Bull,et al. Microbial diversity , 2004, Biodiversity & Conservation.
[113] Cynthia L Sears,et al. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. , 2001, Gastroenterology.
[114] James Kinross,et al. The gut microbiota and host health: a new clinical frontier , 2015, Gut.
[115] Yu-Xiao Yang,et al. Cholecystectomy and the Risk of Colorectal Cancer , 2005, The American Journal of Gastroenterology.
[116] Nod2: a key regulator linking microbiota to intestinal mucosal immunity , 2011, Journal of Molecular Medicine.
[117] Richard A. Moore,et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.
[118] A. Aderem,et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens , 1999, Nature.
[119] D. Green,et al. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. , 2011, Cancer cell.
[120] Seunghyung Lee,et al. Bacteroides fragilis Toxin Induces IL-8 Secretion in HT29/C1 Cells through Disruption of E-cadherin Junctions , 2013, Immune network.
[121] Tianhui Chen,et al. National estimates of cancer prevalence in China, 2011. , 2016, Cancer letters.
[122] Gabriel Cuevas-Ramos,et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells , 2010, Proceedings of the National Academy of Sciences.
[123] Tarah Lynch,et al. Invasive potential of gut mucosa‐derived fusobacterium nucleatum positively correlates with IBD status of the host , 2011, Inflammatory bowel diseases.
[124] N. Barnich,et al. Gut microbiota imbalance and colorectal cancer. , 2016, World journal of gastroenterology.
[125] Gabriel Núñez,et al. Control of pathogens and pathobionts by the gut microbiota , 2013, Nature Immunology.
[126] B. Birren,et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. , 2012, Genome research.
[127] D. Sinderen,et al. Gut microbiota composition correlates with diet and health in the elderly , 2012, Nature.